AB

Arbutus Biopharma

ABUS
NASDAQHealth Care

Recent Patents

abus
over 1 year ago

Filed a patent for "novel lipid formulations for delivery of therapeutic agents" on Thu, September 26, 2024

New US Patent
abus
over 1 year ago

Filed a patent for "targeted nucleic acid conjugate compositions" on Thu, July 25, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "main protease (mpro) inhibitors and methods using same" on Fri, July 15, 2022

New US Patent
abus
almost 2 years ago

Filed a patent for "substituted tricyclic amides, analogues thereof, and methods using same" on Mon, November 14, 2022

New US Patent
abus
almost 2 years ago

Filed a patent for "therapeutic compositions and methods for treating hepatitis b" on Thu, February 15, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "compositions and methods for treating hypertriglyceridemia" on Thu, July 6, 2023

New US Patent
abus
almost 2 years ago

Filed a patent for "novel lipids and compositions for the delivery of therapeutics" on Thu, November 30, 2023

New US Patent
abus
almost 2 years ago

Filed a patent for "lipid compositions" on Thu, February 29, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "lipids and compositions for the delivery of therapeutics" on Thu, February 8, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "targeted conjugates comprising modified sirna" on Thu, February 15, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "lipid formulations for nucleic acid delivery" on Thu, November 23, 2023

New US Patent
abus
almost 2 years ago

Filed a patent for "non-liposomal systems for nucleic acid delivery" on Thu, February 1, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "novel lipid formulations for delivery of therapeutic agents" on Thu, March 28, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "non-liposomal systems for nucleic acid delivery" on Thu, June 6, 2024

New US Patent
abus
almost 2 years ago

Filed a patent for "novel lipid formulations for delivery of therapeutic agents" on Thu, May 9, 2024

New US Patent
abus
2 years ago

Filed a patent for "therapeutic compositions and methods for treating hepatitis b" on Fri, April 22, 2022

New US Patent
abus
2 years ago

Filed a patent for "substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same" on Thu, January 19, 2023

New US Patent
abus
2 years ago

Filed a patent for "methods for ameliorating infusion reactions" on Thu, February 23, 2023

New US Patent
abus
2 years ago

Filed a patent for "compositions and methods for treating hypertriglyceridemia" on Thu, May 26, 2022

New US Patent
abus
2 years ago

Filed a patent for "substituted bicyclic and tricyclic ureas and amides, analogues thereof, and methods using same" on Thu, April 6, 2023

New US Patent
abus
2 years ago

Filed a patent for "trialkyl cationic lipids and methods of use thereof" on Thu, April 6, 2023

New US Patent
abus
2 years ago

Filed a patent for "synthetic processes and intermediates" on Thu, April 13, 2023

New US Patent
abus
2 years ago

Filed a patent for "targeted compositions" on Thu, April 13, 2023

New US Patent
abus
2 years ago

Filed a patent for "lipid containing formulations" on Thu, June 8, 2023

New US Patent
abus
2 years ago

Filed a patent for "novel lipid formulations for delivery of therapeutic agents" on Thu, August 10, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...